Crystal structure of 2-(adamantan-1-yl)-5-(4-bromophenyl)-1,3,4-oxadiazole by Alzoman, Nourah Z. et al.
Crystal structure of 2-(adamantan-1-yl)-
5-(4-bromophenyl)-1,3,4-oxadiazole
Nourah Z. Alzoman,a Ali A. El-Emam,a,b* Hazem A.
Ghabbour,a C. S. Chidan Kumarc,d‡and Hoong-Kun
Funa,c*§
aDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud
University, PO Box 2457, Riaydh 11451, Saudi Arabia, bKing Abdullah Institute for
Nanotechnology (KAIN), King Saud University, Riyadh 11451, Saudi Arabia, cX-ray
Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM,
Penang, Malaysia, and dDepartment of Chemistry, Alva’s Institute of Engineering &
Technology, Mijar, Moodbidri 574225, Karnataka, India. *Correspondence e-mail:
elemam5@hotmail.com, hfun.c@ksu.edu.sa
Received 23 October 2014; accepted 29 October 2014
Edited by C. Rizzoli, Universita degli Studi di Parma, Italy
In the title molecule, C18H19BrN2O, the benzene ring is
inclined to the oxadiazole ring by 10.44 (8). In the crystal,
C—H   interactions link the molecules in a head-to-tail
fashion, forming chains extending along the c-axis direction.
The chains are further connected by – stacking interactions,
with centroid–centroid distances of 3.6385 (7) A˚, forming
layers parallel to the bc plane.
Keywords: crystal structure; adamntane derivative; 1,3,4-oxadiazole; C—
H   hydrogen bonds; – interactions.
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1. Related literature
For the biological activity of adamantane derivatives, see: Al-
Abdullah et al. (2014); Vernier et al. (1969); El-Emam et al.
(2013); Kadi et al. (2010); Balzarini et al. (2009). For the
biological activity of adamantyl-1,3,4- oxadiazole derivatives,
see: Al-Deeb et al. (2006); El-Emam et al. (2004); Kadi et al.
(2007). For related adamantyl 1,3,4-oxadiazole structures, see:
El-Emam et al. (2012); Al-Omary et al. (2014). For related 2,5-
disubstituted 1,3,4-oxadiazole structures, see: Cordes et al.
(2011); Franco et al. (2003). For the synthesis of the title






a = 13.2571 (5) A˚
b = 6.4753 (3) A˚
c = 19.6761 (7) A˚
 = 114.924 (2)
V = 1531.76 (11) A˚3
Z = 4
Mo K radiation
 = 2.69 mm1
T = 293 K






Tmin = 0.520, Tmax = 0.779
39946 measured reflections
4678 independent reflections
3996 reflections with I > 2(I)
Rint = 0.033
2.3. Refinement
R[F 2 > 2(F 2)] = 0.031





max = 0.40 e A˚
3
min = 0.50 e A˚3
Table 1
Hydrogen-bond geometry (A˚, ).
Cg1 is the centroid of the C1–C6 ring.
D—H  A D—H H  A D  A D—H  A
C18—H18B  Cg1i 0.97 2.74 3.6709 (19) 162
Symmetry code: (i) x;y 12; z 32.
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
SHELXTL (Sheldrick, 2008); software used to prepare material for
publication: SHELXTL and PLATON (Spek, 2009).
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Crystal structure of 2-(adamantan-1-yl)-5-(4-bromophenyl)-1,3,4-oxadiazole
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S1. Comment 
Adamantane derivatives have long been known for their diverse biological activities including antiviral activity against 
the influenza (Vernier et al., 1969) and HIV viruses (El-Emam et al., 2004; Balzarini et al., 2009). In addition, Adamantyl 
1,3,4-oxadiazole derivative were reported to exhibit marked antibacterial and anti-inflammatory activities (Kadi et al., 
2007, 2010). In continuation to our interest in the chemical and structural properties of adamantane derivatives (El-Emam 
et al., 2012; Al-Omary et al., 2014) the title compound (I) was prepared as potential bioactive agent.
In the title compound (Fig. 1), the benzene (C1–C6) ring is inclined relative to the oxadiazole (O1/N1/N2/C7/C8) ring 
by a dihedral angle of 10.44 (8)%. Bond lengths (Allen et al., 1987) and angles in the title compound are within normal 
ranges and are comparable with those reported earlier for the structure of related compounds (Cordes et al., 2011; Franco 
et al., 2003). In the crystal structure, the molecules are connected into head-to-tail fashion to form chains extending along 
the c axis via C–H···π interactions (Table 1, Fig. 2) involving the centroid of the C1–C6 benzene ring (Cg1). In addition, 
π–π interactions (Cg1··· Cg1i = 3.6385 (7) Å; symmetry code: (i) -x, -y, 1-z) link the chains into layers parallel to the bc 
plane.
S2. Experimental 
The title compound was prepared following our previously described method (Kadi et al., 2007). A mixture of the 4-
bromobenzoic acid hydrazide (2.15 g, 0.01 mol), 1-adamantane carboxylic acid (1.8 g, 0.01 mol) and phosphorus 
oxychloride (8 ml) was heated under reflux for 1 h. On cooling, crushed ice (50 g) was added cautiously and the mixture 
was stirred for 30 min. The separated crude product was filtered, washed with water, then with a saturated sodium 
hydrogen carbonate solution and finally with water, dried and crystallized from EtOH/CHCl3 (1:1 v/v) to yield 3.16 g 
(88%) of the title compound (C18H19BrN2O) as colorless crystals. M. p.: 188–190 °C.
1H NMR (CDCl3): δ 1.81 (s, 6H, Adamantane-H), 2.15 (s, 9H, Adamantane-H), 7.64 (d, 2H, Ar—H, J = 8.1 Hz), 7.92 
(d, 2H, Ar—H, J = 8.1 Hz). 13 C NMR: δ 27.74, 34.45, 36.29, 39.96 (Adamantane-C), 123.26, 125.99, 128.23, 132.28 
(Ar—C), 163.56 (Oxadiazole C-5), 172.85 (Oxadiazole C-2).
S3. Refinement 
All the H atoms were positioned geometrically (C=H 0.93–0.98 Å) and refined using a riding model with Uiso(H) = 1.2 
Ueq(C).
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Figure 1
The molecular structure of the title compound with 50% probability displacement ellipsoids. 
Figure 2







Hall symbol: -P 2ybc
a = 13.2571 (5) Å
b = 6.4753 (3) Å
c = 19.6761 (7) Å
β = 114.924 (2)°
V = 1531.76 (11) Å3
Z = 4
F(000) = 736
Dx = 1.558 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 9861 reflections
θ = 2.3–30.5°
µ = 2.69 mm−1
T = 293 K
Block, colourless
0.28 × 0.22 × 0.10 mm
Data collection 
Bruker APEXII CCD 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
φ and ω scans
Absorption correction: multi-scan 
(SADABS; Bruker, 2009)
Tmin = 0.520, Tmax = 0.779
39946 measured reflections
4678 independent reflections
3996 reflections with I > 2σ(I)
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Rint = 0.033













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0261P)2 + 1.1502P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max = 0.001
Δρmax = 0.40 e Å−3
Δρmin = −0.50 e Å−3
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used 
only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 
are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
Br1 0.032308 (13) −0.26186 (3) 0.704343 (9) 0.02674 (6)
O1 0.23225 (9) 0.17552 (15) 0.46715 (6) 0.0156 (2)
N1 0.16178 (12) 0.4626 (2) 0.48948 (8) 0.0232 (3)
N2 0.21377 (12) 0.5092 (2) 0.44146 (8) 0.0220 (3)
C1 0.06684 (12) 0.2219 (2) 0.57759 (8) 0.0182 (3)
H1A 0.0403 0.3560 0.5652 0.022*
C2 0.03445 (12) 0.1033 (3) 0.62379 (8) 0.0204 (3)
H2A −0.0139 0.1568 0.6425 0.025*
C3 0.07532 (12) −0.0960 (2) 0.64159 (8) 0.0184 (3)
C4 0.14611 (13) −0.1809 (2) 0.61362 (8) 0.0190 (3)
H4A 0.1722 −0.3153 0.6260 0.023*
C5 0.17744 (12) −0.0626 (2) 0.56699 (8) 0.0184 (3)
H5A 0.2240 −0.1184 0.5472 0.022*
C6 0.13929 (12) 0.1400 (2) 0.54964 (8) 0.0150 (3)
C7 0.17477 (12) 0.2668 (2) 0.50242 (8) 0.0155 (3)
C8 0.25323 (12) 0.3371 (2) 0.43018 (8) 0.0149 (3)
C9 0.32131 (11) 0.2945 (2) 0.38782 (7) 0.0129 (2)
C10 0.43936 (12) 0.2361 (2) 0.44483 (8) 0.0163 (3)
H10A 0.4702 0.3473 0.4807 0.020*
H10B 0.4361 0.1132 0.4720 0.020*
C11 0.51455 (12) 0.1961 (2) 0.40472 (9) 0.0192 (3)
H11A 0.5896 0.1613 0.4417 0.023*
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C12 0.51921 (13) 0.3889 (2) 0.36103 (9) 0.0220 (3)
H12A 0.5668 0.3634 0.3356 0.026*
H12B 0.5501 0.5036 0.3953 0.026*
C13 0.40153 (13) 0.4430 (2) 0.30350 (9) 0.0202 (3)
H13A 0.4046 0.5659 0.2753 0.024*
C14 0.32711 (13) 0.4874 (2) 0.34404 (8) 0.0182 (3)
H14A 0.2530 0.5245 0.3078 0.022*
H14B 0.3572 0.6025 0.3783 0.022*
C15 0.27356 (12) 0.1114 (2) 0.33328 (8) 0.0181 (3)
H15A 0.2698 −0.0105 0.3608 0.022*
H15B 0.1989 0.1439 0.2968 0.022*
C16 0.34879 (13) 0.0691 (2) 0.29311 (9) 0.0210 (3)
H16A 0.3185 −0.0468 0.2583 0.025*
C17 0.46678 (13) 0.0156 (2) 0.35028 (9) 0.0217 (3)
H17A 0.4650 −0.1076 0.3778 0.026*
H17B 0.5137 −0.0117 0.3245 0.026*
C18 0.35327 (14) 0.2619 (3) 0.24913 (9) 0.0240 (3)
H18A 0.3994 0.2350 0.2228 0.029*
H18B 0.2790 0.2962 0.2124 0.029*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
Br1 0.02327 (9) 0.03737 (10) 0.02322 (8) −0.00111 (7) 0.01336 (6) 0.00809 (7)
O1 0.0214 (5) 0.0128 (4) 0.0179 (5) 0.0028 (4) 0.0133 (4) 0.0014 (4)
N1 0.0332 (7) 0.0170 (6) 0.0291 (7) 0.0049 (5) 0.0227 (6) 0.0016 (5)
N2 0.0305 (7) 0.0158 (6) 0.0276 (7) 0.0048 (5) 0.0201 (6) 0.0023 (5)
C1 0.0185 (6) 0.0197 (7) 0.0187 (6) 0.0043 (5) 0.0101 (5) 0.0008 (5)
C2 0.0185 (7) 0.0274 (8) 0.0183 (7) 0.0044 (6) 0.0107 (6) −0.0005 (6)
C3 0.0167 (6) 0.0261 (7) 0.0136 (6) −0.0029 (6) 0.0076 (5) 0.0011 (5)
C4 0.0206 (7) 0.0174 (6) 0.0202 (7) 0.0021 (6) 0.0096 (6) 0.0013 (5)
C5 0.0196 (7) 0.0186 (7) 0.0205 (7) 0.0028 (5) 0.0118 (6) −0.0005 (5)
C6 0.0157 (6) 0.0166 (6) 0.0135 (6) 0.0013 (5) 0.0068 (5) −0.0013 (5)
C7 0.0164 (6) 0.0160 (6) 0.0163 (6) 0.0025 (5) 0.0089 (5) −0.0018 (5)
C8 0.0168 (6) 0.0129 (6) 0.0150 (6) 0.0003 (5) 0.0067 (5) 0.0010 (5)
C9 0.0147 (6) 0.0108 (6) 0.0139 (6) 0.0006 (5) 0.0068 (5) 0.0005 (4)
C10 0.0164 (6) 0.0165 (6) 0.0152 (6) 0.0014 (5) 0.0060 (5) 0.0021 (5)
C11 0.0147 (6) 0.0208 (7) 0.0223 (7) 0.0026 (5) 0.0081 (6) 0.0046 (6)
C12 0.0221 (7) 0.0193 (7) 0.0296 (8) −0.0039 (6) 0.0158 (6) 0.0005 (6)
C13 0.0269 (8) 0.0165 (6) 0.0226 (7) 0.0027 (6) 0.0156 (6) 0.0064 (5)
C14 0.0224 (7) 0.0137 (6) 0.0212 (7) 0.0042 (5) 0.0117 (6) 0.0050 (5)
C15 0.0176 (7) 0.0185 (7) 0.0193 (7) −0.0047 (5) 0.0089 (6) −0.0057 (5)
C16 0.0270 (8) 0.0188 (7) 0.0224 (7) −0.0040 (6) 0.0153 (6) −0.0074 (6)
C17 0.0279 (8) 0.0150 (6) 0.0314 (8) 0.0052 (6) 0.0214 (7) 0.0029 (6)
C18 0.0278 (8) 0.0306 (8) 0.0173 (7) 0.0027 (7) 0.0130 (6) 0.0013 (6)
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Geometric parameters (Å, º) 
Br1—C3 1.8965 (14) C10—H10B 0.9700
O1—C7 1.3629 (16) C11—C17 1.530 (2)
O1—C8 1.3682 (17) C11—C12 1.532 (2)
N1—C7 1.2902 (19) C11—H11A 0.9800
N1—N2 1.4169 (18) C12—C13 1.533 (2)
N2—C8 1.2891 (18) C12—H12A 0.9700
C1—C2 1.389 (2) C12—H12B 0.9700
C1—C6 1.3968 (19) C13—C18 1.534 (2)
C1—H1A 0.9300 C13—C14 1.535 (2)
C2—C3 1.386 (2) C13—H13A 0.9800
C2—H2A 0.9300 C14—H14A 0.9700
C3—C4 1.386 (2) C14—H14B 0.9700
C4—C5 1.386 (2) C15—C16 1.536 (2)
C4—H4A 0.9300 C15—H15A 0.9700
C5—C6 1.396 (2) C15—H15B 0.9700
C5—H5A 0.9300 C16—C17 1.533 (2)
C6—C7 1.4584 (19) C16—C18 1.534 (2)
C8—C9 1.4899 (19) C16—H16A 0.9800
C9—C14 1.5376 (19) C17—H17A 0.9700
C9—C10 1.5397 (19) C17—H17B 0.9700
C9—C15 1.5447 (19) C18—H18A 0.9700
C10—C11 1.532 (2) C18—H18B 0.9700
C10—H10A 0.9700
C7—O1—C8 102.80 (11) C12—C11—H11A 109.6
C7—N1—N2 106.19 (12) C11—C12—C13 109.36 (12)
C8—N2—N1 106.11 (12) C11—C12—H12A 109.8
C2—C1—C6 120.09 (14) C13—C12—H12A 109.8
C2—C1—H1A 120.0 C11—C12—H12B 109.8
C6—C1—H1A 120.0 C13—C12—H12B 109.8
C3—C2—C1 118.96 (13) H12A—C12—H12B 108.3
C3—C2—H2A 120.5 C12—C13—C18 109.63 (13)
C1—C2—H2A 120.5 C12—C13—C14 109.63 (12)
C4—C3—C2 121.79 (14) C18—C13—C14 109.58 (13)
C4—C3—Br1 118.26 (12) C12—C13—H13A 109.3
C2—C3—Br1 119.93 (11) C18—C13—H13A 109.3
C3—C4—C5 119.04 (14) C14—C13—H13A 109.3
C3—C4—H4A 120.5 C13—C14—C9 109.50 (11)
C5—C4—H4A 120.5 C13—C14—H14A 109.8
C4—C5—C6 120.16 (13) C9—C14—H14A 109.8
C4—C5—H5A 119.9 C13—C14—H14B 109.8
C6—C5—H5A 119.9 C9—C14—H14B 109.8
C5—C6—C1 119.93 (13) H14A—C14—H14B 108.2
C5—C6—C7 120.28 (13) C16—C15—C9 109.24 (12)
C1—C6—C7 119.80 (13) C16—C15—H15A 109.8
N1—C7—O1 112.48 (13) C9—C15—H15A 109.8
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N1—C7—C6 128.83 (13) C16—C15—H15B 109.8
O1—C7—C6 118.67 (12) C9—C15—H15B 109.8
N2—C8—O1 112.42 (12) H15A—C15—H15B 108.3
N2—C8—C9 129.92 (13) C17—C16—C18 109.12 (13)
O1—C8—C9 117.56 (12) C17—C16—C15 110.23 (12)
C8—C9—C14 110.37 (11) C18—C16—C15 109.44 (13)
C8—C9—C10 107.90 (11) C17—C16—H16A 109.3
C14—C9—C10 109.40 (11) C18—C16—H16A 109.3
C8—C9—C15 111.30 (11) C15—C16—H16A 109.3
C14—C9—C15 109.70 (12) C11—C17—C16 109.56 (12)
C10—C9—C15 108.11 (11) C11—C17—H17A 109.8
C11—C10—C9 110.40 (11) C16—C17—H17A 109.8
C11—C10—H10A 109.6 C11—C17—H17B 109.8
C9—C10—H10A 109.6 C16—C17—H17B 109.8
C11—C10—H10B 109.6 H17A—C17—H17B 108.2
C9—C10—H10B 109.6 C13—C18—C16 109.45 (12)
H10A—C10—H10B 108.1 C13—C18—H18A 109.8
C17—C11—C10 108.83 (12) C16—C18—H18A 109.8
C17—C11—C12 109.40 (13) C13—C18—H18B 109.8
C10—C11—C12 109.87 (12) C16—C18—H18B 109.8
C17—C11—H11A 109.6 H18A—C18—H18B 108.2
C10—C11—H11A 109.6
C7—N1—N2—C8 −0.10 (18) O1—C8—C9—C15 52.62 (16)
C6—C1—C2—C3 0.1 (2) C8—C9—C10—C11 −178.46 (11)
C1—C2—C3—C4 −1.0 (2) C14—C9—C10—C11 −58.36 (15)
C1—C2—C3—Br1 −179.84 (11) C15—C9—C10—C11 61.06 (15)
C2—C3—C4—C5 0.4 (2) C9—C10—C11—C17 −61.10 (15)
Br1—C3—C4—C5 179.30 (11) C9—C10—C11—C12 58.67 (16)
C3—C4—C5—C6 1.0 (2) C17—C11—C12—C13 60.01 (16)
C4—C5—C6—C1 −1.8 (2) C10—C11—C12—C13 −59.40 (16)
C4—C5—C6—C7 178.16 (14) C11—C12—C13—C18 −59.80 (16)
C2—C1—C6—C5 1.3 (2) C11—C12—C13—C14 60.53 (16)
C2—C1—C6—C7 −178.74 (14) C12—C13—C14—C9 −60.59 (16)
N2—N1—C7—O1 0.28 (18) C18—C13—C14—C9 59.77 (16)
N2—N1—C7—C6 178.56 (14) C8—C9—C14—C13 177.65 (12)
C8—O1—C7—N1 −0.34 (16) C10—C9—C14—C13 59.08 (15)
C8—O1—C7—C6 −178.81 (12) C15—C9—C14—C13 −59.35 (15)
C5—C6—C7—N1 −168.91 (16) C8—C9—C15—C16 −178.05 (12)
C1—C6—C7—N1 11.1 (2) C14—C9—C15—C16 59.51 (15)
C5—C6—C7—O1 9.3 (2) C10—C9—C15—C16 −59.72 (15)
C1—C6—C7—O1 −170.73 (13) C9—C15—C16—C17 59.96 (16)
N1—N2—C8—O1 −0.12 (17) C9—C15—C16—C18 −60.05 (16)
N1—N2—C8—C9 −176.25 (14) C10—C11—C17—C16 59.51 (15)
C7—O1—C8—N2 0.27 (16) C12—C11—C17—C16 −60.55 (15)
C7—O1—C8—C9 176.93 (12) C18—C16—C17—C11 60.45 (15)
N2—C8—C9—C14 −9.4 (2) C15—C16—C17—C11 −59.76 (16)
O1—C8—C9—C14 174.68 (12) C12—C13—C18—C16 59.93 (16)
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N2—C8—C9—C10 110.13 (17) C14—C13—C18—C16 −60.43 (16)
O1—C8—C9—C10 −65.84 (15) C17—C16—C18—C13 −60.03 (16)
N2—C8—C9—C15 −131.41 (16) C15—C16—C18—C13 60.66 (16)
Hydrogen-bond geometry (Å, º) 
Cg1 is the centroid of the C1–C6 ring.
D—H···A D—H H···A D···A D—H···A
C18—H18B···Cg1i 0.97 2.74 3.6709 (19) 162
Symmetry code: (i) x, −y−1/2, z−3/2.
